MDL 3079 · JPML

IN RE: Tepezza Marketing, Sales Practices, and Products Liability Litigation

Court: ILN · Judge: Thomas M. Durkin (U.S. District Judge)

279 pending civil actions

+2 month over month (since September 1, 2026).

Transfer-order alleged injury · 2023-06-02

the alleged propensity of the biologic drug Tepezza, which treats thyroid eye disease, to cause severe or permanent hearing loss and tinnitus

Plaintiffs’ allegations, not court findings. Transfer order